Thermo Fisher Scientific (TMO) Short-term Investments (2009 - 2026)

Thermo Fisher Scientific has disclosed Short-term Investments across 11 years of filings, most recently posting $2.0 million for Q1 2026.

• Quarterly Short-term Investments fell 99.89% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 99.89% YoY) and the FY2025 annual result came in at $253.0 million, down 83.79% from the prior year.
• Short-term Investments fell to $2.0 million in Q1 2026, from $253.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $2.0 billion in Q3 2024 and troughed at $2.0 million in Q1 2026.
• A 4-year average of $1.3 billion and a median of $1.7 billion in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments jumped 51933.33% — and 2026, when it slumped 99.89%.
• Tracing TMO's Short-term Investments over 4 years: stood at $3.0 million in 2023, then soared by 51933.33% to $1.6 billion in 2024, then plunged by 83.79% to $253.0 million in 2025, then slumped by 99.21% to $2.0 million in 2026.
• Business Quant data shows TMO's Short-term Investments at $2.0 million in Q1 2026, $253.0 million in Q4 2025, and $1.6 billion in Q3 2025.